Amplify Weight Loss Drug ... (THNR)
NYSEArca: THNR
· 실시간 가격 · USD
27.19
+0.73 (2.76%)
종가 기준: Aug 18, 2026, 10:57 AM
Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Price, Holdings & Analysis
2.76% (1D)
| 매수호가 | 27.17 |
| 시가총액 | n/a |
| 운용자산 | 5.07M |
| 순자산가치 | 26.22 |
| 베타 | n/a |
| EPS (최근 12개월) | n/a |
| P/E (최근 12개월) | 19.69 |
| 발행 주식수 | n/a |
| 설정일 | May 20, 2024 |
| 매도호가 | 27.2 |
| 거래량 | 5,177 |
| 평균 거래량 (20일) | 2,067 |
| 시가 | 27.14 |
| 전일 종가 | 26.46 |
| 당일 변동폭 | 27.14 - 27.35 |
| 52주 변동폭 | 22.63 - 27.35 |
| 편입 종목 | n/a |
| 총보수 | 0.59% |
THNR 정보
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
상위 10종목 자산의 61.60%
| 이름 | 종목코드 | 비중 |
|---|---|---|
| Novo Nordisk As Adr | NVO | 9.70% |
| Eli Lilly And Co | LLY | 8.92% |
| Regeneron Pharmaceut... | REGN | 6.03% |
| Cspc Pharmaceutical ... | 1093.HK | 5.52% |
| Arrowhead Pharmaceut... | ARWR | 5.34% |
| Innovent Biologics I... | 1801.HK | 5.34% |
| Amgen Inc | AMGN | 5.25% |
| Abbvie Inc | ABBV | 5.24% |
| Roche Holding Ag Ord... | ROP.SW | 5.20% |
| Merck & Co Inc | MRK | 5.06% |
2 페이지 중 1